Abstract
Because of the high surface energy, nanoparticles show strong tendency to agglomeration or aggregation during preparations and applications, which thus greatly deteriorate their performance. Investigations have proven that redispersible nanoparticles can exhibit enhanced performances or be used in new technical applications as compared with the non-redispersible nanoparticles. The redispersity or solubility of particles is defined as their ability for re-forming colloidlike suspension after they are redispersed in solvent. The redispersity/solubility of particles can be obtained by establishing compatibility between particles and solvent through various techniques. In this review, we will give summary descriptions about related methods and their mechanism for the fabrication of redispersible or soluble particles. Also, outlook for the development and applications in this area will be given.
Keywords: Nanoparticles, redispersity, solubility, surface modification.
Recent Patents on Nanotechnology
Title:Redispersity/Solubility of Nanopowder in Solvents
Volume: 8 Issue: 1
Author(s): Yunan Zhao, Minmin Wang, Yan Liu and Hongtao Cui
Affiliation:
Keywords: Nanoparticles, redispersity, solubility, surface modification.
Abstract: Because of the high surface energy, nanoparticles show strong tendency to agglomeration or aggregation during preparations and applications, which thus greatly deteriorate their performance. Investigations have proven that redispersible nanoparticles can exhibit enhanced performances or be used in new technical applications as compared with the non-redispersible nanoparticles. The redispersity or solubility of particles is defined as their ability for re-forming colloidlike suspension after they are redispersed in solvent. The redispersity/solubility of particles can be obtained by establishing compatibility between particles and solvent through various techniques. In this review, we will give summary descriptions about related methods and their mechanism for the fabrication of redispersible or soluble particles. Also, outlook for the development and applications in this area will be given.
Export Options
About this article
Cite this article as:
Zhao Yunan, Wang Minmin, Liu Yan and Cui Hongtao, Redispersity/Solubility of Nanopowder in Solvents, Recent Patents on Nanotechnology 2014; 8 (1) . https://dx.doi.org/10.2174/1872210507999131128103202
DOI https://dx.doi.org/10.2174/1872210507999131128103202 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Prevalence of Pre-Existing Risk Factors for Adverse Events Associated with Atypical Antipsychotics Among Commercially Insured and Medicaid Insured Patients Newly Initiating Atypical Antipsychotics
Current Drug Safety The Nuclear Transcription Factor CREB: Involvement in Addiction, Deletion Models and Looking Forward
Current Neuropharmacology Substance P and Alzheimer’s Disease: Emerging Novel Roles
Current Alzheimer Research A Genetic Dissection of Antipsychotic Induced Movement Disorders
Current Medicinal Chemistry Situating Nutri-Ethics at the Junction of Nutrigenomics and Nutriproteomics in Postgenomics Medicine
Current Pharmacogenomics and Personalized Medicine A Current Perspective on the Inhibition of Cholinesterase by Natural and Synthetic Inhibitors
Current Drug Metabolism Cannabidiol as a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development
Current Pharmacogenomics and Personalized Medicine Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury
Current Neuropharmacology EDITORIAL (Thematic Issue: New Targets of Medical Treatment in Psychiatric Disorders)
Current Neuropharmacology Inhibition of Ceramide Metabolism Key Enzymes and its Implication in Cell Physiology and Pathology
Current Enzyme Inhibition Astrocytes as a 5-HT2B-Mediated SERT-Independent SSRI Target, Slowly Altering Depression-Associated Genes and Function
Current Signal Transduction Therapy A New Drug Candidate (GEMSP) for Multiple Sclerosis
Current Medicinal Chemistry Inflamm-Aging, Cytokines and Aging: State of the Art, New Hypotheses on the Role of Mitochondria and New Perspectives from Systems Biology
Current Pharmaceutical Design Novel Anti-Inflammatory and Neuroprotective Agents for Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Algorithmic and Stochastic Representations of Gene Regulatory Networks and Protein-Protein Interactions
Current Topics in Medicinal Chemistry Mitochondria-Targeting Anticancer Metal Complexes
Current Medicinal Chemistry Tau Oligomerization: A Role for Tau Aggregation Intermediates Linked to Neurodegeneration
Current Alzheimer Research The Genetics of Frontotemporal Dementia and Related Disorders
Current Genomics Comparison with Naloxone of Two Dynorphin a Analogues with K- and δ-Opioid Antagonist Activity
Medicinal Chemistry